仟源医药：8月8日召开董事会会议

Group 1 - The core point of the article is that QianYuan Pharmaceutical announced the convening of its 31st meeting of the 5th Board of Directors via communication voting on August 8, 2025, to discuss the proposal for the 4th extraordinary shareholders' meeting of 2025 [2] - For the year 2024, QianYuan Pharmaceutical's revenue composition is as follows: pharmaceutical manufacturing accounts for 96.68%, DNA gene preservation and prenatal environment testing services account for 1.93%, health food accounts for 0.79%, other businesses account for 0.51%, and commercial activities account for 0.1% [2]